# Acute Treatment Trial in Adult Subjects With Migraines

> **NCT03872453** · PHASE2,PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 2154 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Zavegepant
- **DRUG:** Zavegepant matching placebo
- **DEVICE:** Intranasal Aptar Pharma Unit Dose System

## Key facts

- **NCT ID:** NCT03872453
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-25
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-11-11
- **Target enrollment:** 2154 (ACTUAL)
- **Last updated:** 2023-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03872453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03872453, "Acute Treatment Trial in Adult Subjects With Migraines". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03872453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*